Kepos Capital LP Evaxion Biotech A/S Transaction History

Kepos Capital LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$1.6 - $3.07 $48,000 - $92,100	-30,000 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$2.66 - $4.65 $26,600 - $46,500	-10,000 Reduced 25.0%	30,000 $91,000
Q4 2021 Feb 14, 2022	BUY	$4.0 - $12.68 $11,608 - $36,797	2,902 Added 7.82%	40,000 $177,000
Q1 2021 May 13, 2021	BUY	$5.3 - $9.95 $196,619 - $369,125	37,098 New	37,098 $219,000

37.5K

Ticker EVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 23,977,900
Market Cap $20.6M
Description
Evaxion Biotech A/S, a clinical-stage biotech company, engages in developing artificial intelligence-powered immunotherapies for cancers, bacterial diseases, and viral infections. The company develops EVX-01, a cancer immunotherapy that is in clinical Phase IIb trial for metastatic melanoma; EVX-02, a DNA-based cancer immunotherapy that is in Ph...

Get notified when there are updates to the investment portfolio of Kepos Capital LP, based on Form 13F filings with the SEC.

Stay updated on Kepos Capital LP with notifications on news.